CRO Invests $10m into Baltimore Early-Stage Embedded Trial Site--Part of Medstar Harbor Hospital

Clinical Research Organization (CRO) Parexel has spent $10 million at MedStar Harbor Hospital’s seventh floor as part of its ongoing improvement to improve patient experience at the hospital and trial site. One of the world’s largest CROs, this particular embedded research unit for early-stage clinical trials is one of four in the world operated by Parexel.

Patients participating in early-stage clinical trials at this Baltimore-based hospital and trial site benefit from significant improvements, including a view given the trial site operation runs out of the 7^th floor in Cherry Hill in Baltimore.